News
A Yale pharmacologist pursues the therapeutic potential of a psychedelic drug
Pharmacologist Gary Rudnick, Ph.D., names coffee as his personal drug of choice. He’s spent most of his career studying the serotonin transporter, a regulator of neuronal signaling, which is inhibited by such drugs as the antidepressants Lexapro and Prozac. But in the last few years, his research has led him to probe the pharmacological potential of a drug off the beaten path: the hallucinogen ibogaine, which is illegal in the United States. Its medical appeal? Anecdotal reports suggesting that the drug can help opiate addicts kick their habits.
Source: Yale Medicine